Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways

References

• LiYLinZZhaoMSilver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathwaysACS Appl Mater Interfaces2016837243852439327588566
   PubMed Web of Science ®Google Scholar
• WangCZHanHHTangXYSialylglycan-assembled supra-dots for ratiometric probing and blocking of human-infecting influenza virusesACS Appl Mater Interfaces2017930251642517028703004
   PubMed Web of Science ®Google Scholar
• YangMSunderlandKMaoCVirus-derived peptides for clinical applicationsChem Rev201711715103771040228723101
   PubMed Web of Science ®Google Scholar
• LiYHLinZFZhaoMQReversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadineRSC Adv20166928967989686
   Web of Science ®Google Scholar
• LiYLinZGuoMInhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virusInt J Nanomedicine2017125733574328848350
   PubMed Web of Science ®Google Scholar
• JungJHParkBHOhSJChoiGSeoTSIntegration of reverse transcriptase loop-mediated isothermal amplification with an immunochromatographic strip on a centrifugal microdevice for influenza A virus identificationLab Chip201515371872525426967
   PubMed Web of Science ®Google Scholar
• LovedayEKDiederichSPasickJJeanFHuman microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furinJ Gen Virol201596Pt 1303925234642
   PubMedGoogle Scholar
• LondriganSLShortKRMaJInfection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at a late stage in the virus life cycleJ Virol20158924123191232926423941
   PubMed Web of Science ®Google Scholar
• LiuYZhangLWeiWColorimetric detection of influenza A virus using antibody-functionalized gold nanoparticlesAnalyst2015140123989399525899840
   PubMed Web of Science ®Google Scholar
• HaiWGodaTTakeuchiHSpecific recognition of human influenza virus with PEDOT bearing sialic acid-terminated trisaccharidesACS Appl Mater Interfaces2017916141621417028379685
   PubMed Web of Science ®Google Scholar
• LinZLiYGuoMThe inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivirRSC Adv201772742750
   Web of Science ®Google Scholar
• LinZLiYGuoMInhibition of H1N1 influenza virus by selenium nanoparticles loaded with zanamivir through p38 and JNK signaling pathwaysRSC Adv20177563529035296
   Web of Science ®Google Scholar
• ChenQGuoYInfluenza viral hemagglutinin peptide inhibits influenza viral entry by shielding the host receptorACS Infect Dis20162318719327623031
   PubMed Web of Science ®Google Scholar
• GleedMLBusathDDWhy bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N)J Phys Chem B201511931225123125426702
   PubMed Web of Science ®Google Scholar
• GleedMLIoannidisHKolocourisABusathDDResistance-mutation (N31) effects on drug orientation and channel hydration in amantadine-bound influenza A M2J Phys Chem B201511935115481155926268449
   PubMed Web of Science ®Google Scholar
• Rey-CarrizoMBarniol-XicotaMMaCEasily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virusJ Med Chem201457135738574724941437
   PubMed Web of Science ®Google Scholar
• WuYCanturkBJoHFlipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant 531N mutant of the influenza A virus M2 proton channelJ Am Chem Soc201413652179871799525470189
   PubMed Web of Science ®Google Scholar
• DurrantMGEggettDLBusathDDInvestigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequenceBMC Genet201516Suppl 2S325953496
   PubMed Web of Science ®Google Scholar
• Van NguyenHNguyenHTLeLTInvestigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocketEur Biophys J2016451637026391902
   PubMed Web of Science ®Google Scholar
• de SouzaESilvaJMHanchukTDSantosMIKobargJBajgelmanMCCardosoMBViral inhibition mechanism mediated by surface- modified silica nanoparticlesACS Appl Mater Interfaces2016826165641657227284685
   PubMed Web of Science ®Google Scholar
• GustafssonSMihranyanAStrategies for tailoring the pore-size distribution of virus retention filter papersACS Appl Mater Interfaces2016822137591376727144657
   PubMed Web of Science ®Google Scholar
• LiYHLinZFXuTTDelivery of VP1 siRNA to inhibit the EV71 virus using functionalized silver nanoparticles through ROS-mediated signaling pathwaysRSC Adv20177314531463
   Web of Science ®Google Scholar
• TaoWHurstBLShakyaAKConsensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A virusesAntiviral Res2017141627228161578
   PubMed Web of Science ®Google Scholar
• YeSShaoKLiZAntiviral activity of graphene oxide: how sharp edged structure and charge matterACS Appl Mater Interfaces2015738215712157926370151
   PubMed Web of Science ®Google Scholar
• VonnemannJSiebenCWolffCVirus inhibition induced by polyvalent nanoparticles of different sizesNanoscale2014642353236024430614
   PubMed Web of Science ®Google Scholar
• SokolovaVWestendorfAMBuerJUberlaKEppleMThe potential of nanoparticles for the immunization against viral infectionsJ Mater Chem B201532447674779
   PubMed Web of Science ®Google Scholar
• WangJZhuRGaoBThe enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvantBiomaterials201435146647824099705
   PubMed Web of Science ®Google Scholar
• WangJLiuYXuKBroad-spectrum antiviral property of polyoxometalate localized on a cell surfaceACS Appl Mater Interfaces20146129785978924878685
   PubMed Web of Science ®Google Scholar
• BarrasAPagneuxQSaneFHigh efficiency of functional carbon nanodots as entry inhibitors of herpes simplex virus type 1ACS Appl Mater Interfaces20168149004901327015417
   PubMed Web of Science ®Google Scholar
• KhanalMVausselinTBarrasAPhenylboronic-acid-modified nanoparticles: potential antiviral therapeuticsACS Appl Mater Interfaces2013523124881249824180242
   PubMed Web of Science ®Google Scholar
• RamyaSShanmugasundaramTBalagurunathanRBiomedical potential of actinobacterially synthesized selenium nanoparticles with special reference to anti-biofilm, anti-oxidant, wound healing, cytotoxic and anti-viral activitiesJ Trace Elem Med Biol201532303926302909
   PubMed Web of Science ®Google Scholar
• StevanovicMFilipovicNDjurdjevicJLukicMMilenkovicMBoccacciniA45S5Bioglass (R)-based scaffolds coated with selenium nanoparticles or with poly(lactide-co-glycolide)/selenium particles: processing, evaluation and antibacterial activityColloids Sur B Biointerfaces2015132208215
   PubMed Web of Science ®Google Scholar
• YangYXieQZhaoZNFunctionalized selenium nanosystem as radiation sensitizer of I-125 seeds for precise cancer therapyACS Appl Mater Interfaces2017931258572586928718286
   PubMed Web of Science ®Google Scholar
• JiangWFuYYangFGracilaria lemaneiformis polysaccharide as integrin-targeting surface decorator of selenium nanoparticles to achieve enhanced anticancer efficacyACS Appl Mater Interfaces2014616137381374825073123
   PubMed Web of Science ®Google Scholar
• HuangYLuoYZhengWChenTRational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistanceACS Appl Mater Interfaces2014621192171922825314331
   PubMed Web of Science ®Google Scholar
• YuLSunLNanYZhuLYProtection from H1N1 influenza virus infections in mice by supplementation with selenium: a comparison with selenium-deficient miceBiol Trace Elem Res20111411–325426120490710
   PubMed Web of Science ®Google Scholar
• ChengZZhiXSunGSodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell linesJ Med Virol201688465366326331371
   PubMed Web of Science ®Google Scholar
• LiYLinZZhaoMMultifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cellsInt J Nanomedicine2016113065307627462151
   PubMed Web of Science ®Google Scholar
• LiYGuoMLinZPolyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosisInt J Nanomedicine2016116693670227994465
   PubMed Web of Science ®Google Scholar
• ZhuBLiYLinZSilver nanoparticles induce HePG-2 cells apoptosis through ROS-mediated signaling pathwaysNanoscale Res Lett20161119826909778
   PubMedGoogle Scholar
• LiuWLiXWongYSSelenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergismACS Nano2012686578659122823110
   PubMed Web of Science ®Google Scholar
• LiYLiXWongYSThe reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosisBiomaterials201132349068907621864903
   PubMed Web of Science ®Google Scholar
• XiangDXChenQPangLZhengCLInhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitroJ Virol Methods20111781–213714221945220
   PubMed Web of Science ®Google Scholar
• XiaoSSiLTianZPentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: a dramatic multivalent effectBiomaterials201678748526686050
   PubMed Web of Science ®Google Scholar
• ZhangYLiXHuangZZhengWFanCChenTEnhancement of cell permeabilization apoptosis-inducing activity of selenium nanoparticles by ATP surface decorationNanomedicine201391748422542821
   PubMed Web of Science ®Google Scholar
• WuHLiXLiuWSurface decoration of selenium nanoparticles by mushroom polysaccharides-protein complexes to achieve enhanced cellular uptake and antiproliferative activityJ Mater Chem2012221996029610
   Web of Science ®Google Scholar
• LiYLiXZhengWFanCZhangYChenTFunctionalized selenium nanoparticles with nephroprotective activity, the important roles of ROS-mediated signaling pathwaysJ Mater Chem2012221996029610
   Google Scholar
• LiXMaLZhengWChenTInhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosisBiomaterials201435308596860425034964
   PubMed Web of Science ®Google Scholar
• LiJMWangYYZhaoMXMultifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time trackingBiomaterials20123392780279022243797
   PubMed Web of Science ®Google Scholar
• FuXYangYLiXRGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathwayNanomedicine20161261627163926961468
   PubMed Web of Science ®Google Scholar
• XiaYLinZLiYTargeted delivery of siRNA using RGDfC-conjugated functionalized selenium nanoparticles for anticancer therapyJ Mater Chem B201753369416952
   PubMed Web of Science ®Google Scholar